Genomate logo
Genomate logo

Genomate

genomate.health
genomate.health • HQ: Cambridge, United States • Convertible Note 2025 • 51-200 employees • Founded 2022 • Startup • New
HQ: Cambridge, United States • Convertible Note 2025 • 51-200 employees • Founded 2022 • Startup • New
Actively hiring
Precision Medicine
Artificial Intelligence
Health Care
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$10.4M
3 rounds on record
Latest round
$2M
Convertible Note · Mar 2025 · 18 mo ago
Team
51-200
employees, estimated range
The money's age
Due for its next round
18 months since the last round · not hiring
Momentum
0/100
no fresh signals
Funding rounds
RoundDateAmountInvestorsSource
Convertible Note Mar 2025 $2M — SEC Form D
Convertible Note Oct 2023 $2.7M — SEC Form D
Convertible Note Oct 2022 $5.7M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity GENOMATE HEALTH, INC. sec
Founders and leadersfrom filings, registers and the company's site
Istvan PetakExecutive Officer, DirectorSEC Form D
Similar startupsby what they do, their industry and backers
Omica
Precision oncology, built for Latin America. Point-of-care software and a multimodal cancer atlas.
Blank BioSeed $7.2M · 4 mo ago
RNA intelligence for precision oncology. Blank Bio builds AI foundation models that help pharma teams identify the right patients for…
GenialisVenture round $11.4M · 3 yr ago
Genialis is a precision oncology company helping the most promising molecules become life-saving medicines.
Scipher MedicineVenture round $5.8M · 2 yr ago • Founded 2013 • 201-500 employees
Transforming Treatment in Immunology. Living at the crossroads of precision medicine and AI, Scipher Medicine is a precision immunology…
CellplyVenture round $7.7M · 4 mo ago • 51-200 employees • 1 role
Cellply offers an automated platform for functional precision medicine.
DoMore DiagnosticsFounded 2020 • 1-10 employees
DoMore Diagnostics is on a mission to transform cancer diagnostics with artificial intelligence to improve patient care and make drug…

Overview

Genomate helps physicians find the right targeted therapy for every cancer patient based on the individual molecular profile of their tumor. AI-powered precision oncology. The right drug. The first time. Every time.

People

Istvan Petak
Executive Officer, Director
SEC Form D
Richard Schwab
Director
SEC Form D
Jared Schrieber
Director
SEC Form D
Scott Friedman
Director
SEC Form D
Laszlo Mechtler
Director
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Cambridge United States
HQ
50-200 est. staff

Financials

Total raised
$10.4M
Latest round
Convertible Note
Funding rounds
3
Funding rounds
Round Announced Amount
Convertible Note 2025 $2M Details
Convertible Note 2023 $2.7M Details
Convertible Note 2022 $5.7M Details